Cancer Stem Cells: Technologies and Global Markets
Report Scope:
This research report presents an in-depth analysis of the global cancer stem cells market by cancer type and geographic markets. The report includes key inhibitors that affect various factors that help in growth of cancer stem cells. The report discusses the roles of supply chain members from manufacturers to researchers. The report has an in-depth analysis of key companies operating in the global cancer stem cells market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and geographies such as the U.S., Europe and China.
The cancer stem cells market is mainly segmented into two major components: cancer type and geography. Based on cancer type, the market is segmented into lung cancer, breast cancer, colorectal cancer, leukemia, melanoma, prostate cancer, brain cancer, bone cancer and other types of cancer. The market is segmented by geography into North America, Europe, Asia-Pacific and RoW.
Report Includes:
This research report presents an in-depth analysis of the global cancer stem cells market by cancer type and geographic markets. The report includes key inhibitors that affect various factors that help in growth of cancer stem cells. The report discusses the roles of supply chain members from manufacturers to researchers. The report has an in-depth analysis of key companies operating in the global cancer stem cells market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and geographies such as the U.S., Europe and China.
The cancer stem cells market is mainly segmented into two major components: cancer type and geography. Based on cancer type, the market is segmented into lung cancer, breast cancer, colorectal cancer, leukemia, melanoma, prostate cancer, brain cancer, bone cancer and other types of cancer. The market is segmented by geography into North America, Europe, Asia-Pacific and RoW.
Report Includes:
- 50 tables
- An overview of the global market and technologies for cancer stem cells
- Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Coverage of history, synthesis, isolation, identification and characteristics of cancer stem cells, and description of stem cell transplant types i.e., autologous, allogeneic, and syngeneic
- Detailed description of cancer stem cells, its pathophysiology and affects and major advancement of the industry and discussion on side effects of stem cells implantation
- Discussion on the future of stem cells for the treatment of COVID-19 and information about advancing stem cells to mainstream medicines for COVID-19
- Assessment of regulatory structure, pricing, and reimbursement scenarios; marketed and pipeline (R&D) products, and clinical trials
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
- Comprehensive company profiles of the leading players of the industry including AdnaGen AG, Advanced Cell Diagnostics Inc., BioNTech, Caladrius Biosciences Inc., Celgene Corp., ExCellThera, Gamida Cell, Silicon Biosystems and ViaCyte Inc.
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report?
Scope of Report
Information Sources and Methodology
Intended Audience
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Market Definition and Scope
History of Cancer Stem Cells
Synthesis, Isolation and Identification of CSCs
Characteristics of Cancer Stem Cells
Metastasizing Tumor Cells
Apoptosis
Resistance to Chemotherapy
Stem Cell Classification
Based on Ability to Differentiate
Based on Source
Mechanism of Action
Targeting Signaling Pathways
Targeting CSCs Markers
Targeting miRNA Expression
Targeting CSCs' Niche
Stem Cell Transplants
Autologous
Allogeneic
Syngeneic
Cancer Stem Cell Clinical Pipeline
CHAPTER 4 MARKET DYNAMICS
Market Dynamics
Drivers
Increase in Cancer Research Activities
Increase in Incidence and Mortality Rate of Cancer
Restraints
Ethical Issues
High Cost Associated with Cancer Stem Cell Therapeutics
Opportunity
Increasing Cancer Stem Cell Research
Successful Implementation of CSC as a Therapeutic Tool in Animals
CHAPTER 5 MARKET BREAKDOWN BY CANCER TYPE
Lung Cancer
Incidence of Lung Cancer
Risk Factors
Types of Lung Cancer
Site of Lung Tumor Initiation
Lung Cancer Stem Cells as Therapeutic Targets
Breast Cancer
Incidence and Mortality Rate of Breast Cancer
Types of Breast Cancer
Site of Tumor Initiation
Breast Cancer Stem Cells as Therapeutic Targets
Colorectal Cancer
Incidence and Mortality of Colorectal Cancer
Colorectal Cancer Stem Cells as Therapeutic Targets
Leukemia
Incidence and Mortality of Leukemia
Leukemia Stem Cells as Therapeutic Targets
Melanoma
Incidence and Mortality of Melanoma
Melanoma Cancer Stem Cells as Therapeutic Targets
Prostate Cancer
Incidence and Mortality Rate of Prostate Cancer
Prostate Cancer Stem Cells as Therapeutic Targets
Brain Cancer
Incidence of Brain Cancer
Brain Cancer Stem Cells as Therapeutic Targets
Bone Cancer
Bone Cancer Stem Cells as Therapeutic Targets
Others
CHAPTER 6 MARKET BREAKDOWN BY REGION
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
Rest of Asia-Pacific
Rest of the World (RoW)
Brazil
GCC Countries
Rest of the World Countries
CHAPTER 7 COVID-19 AND STEM CELL RESEARCH
Impact of Early-Stage Research
Advancing Stem Cells to Mainstream Medicines for COVID-19
The Future of Stem Cells for the Treatment of COVID-19
CHAPTER 8 COST OF STEM CELL THERAPY IN 2021
Types of Stem Cell Therapy
Stem Cell Therapy is Expensive- Why?
Ethics and Regulations for Stem Cell Therapy
CHAPTER 9 COMPETITIVE LANDSCAPE
Global Company Ranking Analysis
Start-up on Regenerative Therapeutics or Stem Cell Therapeutics
CHAPTER 10 COMPANY PROFILES
ADNAGEN AG
ADVANCED CELL DIAGNOSTICS INC.
APCETH BIOPHARMA
AVIVA BIOSCIENCES CORP.
BIONTECH
BENITEC BIOPHARMA
CALADRIUS BIOSCIENCES
CELGENE CORP.
EPIC SCIENCES INC.
EXCELLTHERA
FLUXION BIOSCIENCES INC.
GALENA BIOPHARMA
GAMIDA CELL
GENEXINE
GERON
IMMUNOCELLULAR THERAPEUTICS
ONCOCYTE CORP.
ONCOMED PHARMACEUTICALS INC.
PLURISTEM THERAPEUTICS INC.
SILICON BIOSYSTEMS S.P.A
SPHERE FLUIDICS LTD.
VIACYTE INC.
VITATEX INC.
CHAPTER 11 LIST OF PATENTS
North American Patents on Cancer Stem Cells
European Patents on Cancer Stem Cells
Asia-Pacific Patents on Cancer Stem Cells
RoW Patents on Cancer Stem Cells
CHAPTER 12 APPENDIX: ACRONYMS
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report?
Scope of Report
Information Sources and Methodology
Intended Audience
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Market Definition and Scope
History of Cancer Stem Cells
Synthesis, Isolation and Identification of CSCs
Characteristics of Cancer Stem Cells
Metastasizing Tumor Cells
Apoptosis
Resistance to Chemotherapy
Stem Cell Classification
Based on Ability to Differentiate
Based on Source
Mechanism of Action
Targeting Signaling Pathways
Targeting CSCs Markers
Targeting miRNA Expression
Targeting CSCs' Niche
Stem Cell Transplants
Autologous
Allogeneic
Syngeneic
Cancer Stem Cell Clinical Pipeline
CHAPTER 4 MARKET DYNAMICS
Market Dynamics
Drivers
Increase in Cancer Research Activities
Increase in Incidence and Mortality Rate of Cancer
Restraints
Ethical Issues
High Cost Associated with Cancer Stem Cell Therapeutics
Opportunity
Increasing Cancer Stem Cell Research
Successful Implementation of CSC as a Therapeutic Tool in Animals
CHAPTER 5 MARKET BREAKDOWN BY CANCER TYPE
Lung Cancer
Incidence of Lung Cancer
Risk Factors
Types of Lung Cancer
Site of Lung Tumor Initiation
Lung Cancer Stem Cells as Therapeutic Targets
Breast Cancer
Incidence and Mortality Rate of Breast Cancer
Types of Breast Cancer
Site of Tumor Initiation
Breast Cancer Stem Cells as Therapeutic Targets
Colorectal Cancer
Incidence and Mortality of Colorectal Cancer
Colorectal Cancer Stem Cells as Therapeutic Targets
Leukemia
Incidence and Mortality of Leukemia
Leukemia Stem Cells as Therapeutic Targets
Melanoma
Incidence and Mortality of Melanoma
Melanoma Cancer Stem Cells as Therapeutic Targets
Prostate Cancer
Incidence and Mortality Rate of Prostate Cancer
Prostate Cancer Stem Cells as Therapeutic Targets
Brain Cancer
Incidence of Brain Cancer
Brain Cancer Stem Cells as Therapeutic Targets
Bone Cancer
Bone Cancer Stem Cells as Therapeutic Targets
Others
CHAPTER 6 MARKET BREAKDOWN BY REGION
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
Rest of Asia-Pacific
Rest of the World (RoW)
Brazil
GCC Countries
Rest of the World Countries
CHAPTER 7 COVID-19 AND STEM CELL RESEARCH
Impact of Early-Stage Research
Advancing Stem Cells to Mainstream Medicines for COVID-19
The Future of Stem Cells for the Treatment of COVID-19
CHAPTER 8 COST OF STEM CELL THERAPY IN 2021
Types of Stem Cell Therapy
Stem Cell Therapy is Expensive- Why?
Ethics and Regulations for Stem Cell Therapy
CHAPTER 9 COMPETITIVE LANDSCAPE
Global Company Ranking Analysis
Start-up on Regenerative Therapeutics or Stem Cell Therapeutics
CHAPTER 10 COMPANY PROFILES
ADNAGEN AG
ADVANCED CELL DIAGNOSTICS INC.
APCETH BIOPHARMA
AVIVA BIOSCIENCES CORP.
BIONTECH
BENITEC BIOPHARMA
CALADRIUS BIOSCIENCES
CELGENE CORP.
EPIC SCIENCES INC.
EXCELLTHERA
FLUXION BIOSCIENCES INC.
GALENA BIOPHARMA
GAMIDA CELL
GENEXINE
GERON
IMMUNOCELLULAR THERAPEUTICS
ONCOCYTE CORP.
ONCOMED PHARMACEUTICALS INC.
PLURISTEM THERAPEUTICS INC.
SILICON BIOSYSTEMS S.P.A
SPHERE FLUIDICS LTD.
VIACYTE INC.
VITATEX INC.
CHAPTER 11 LIST OF PATENTS
North American Patents on Cancer Stem Cells
European Patents on Cancer Stem Cells
Asia-Pacific Patents on Cancer Stem Cells
RoW Patents on Cancer Stem Cells
CHAPTER 12 APPENDIX: ACRONYMS
LIST OF TABLES
Summary Table: Global Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 1: Clinical Trials on Cancer Stem Cells
Table 2: Global Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 3: Global Market for Cancer Stem Cells for Lung Cancer, by Region, Through 2026
Table 4: Global Market for Cancer Stem Cells for Breast Cancer, by Region, Through 2026
Table 5: Global Market for Cancer Stem Cells for Colorectal Cancer, by Region, Through 2026
Table 6: Global Market for Cancer Stem Cells for Leukemia, by Region, Through 2026
Table 7: Global Market for Cancer Stem Cells for Melanoma, by Region, Through 2026
Table 8: Global Market for Cancer Stem Cells for Prostate Cancer, by Region, Through 2026
Table 9: Global Market for Cancer Stem Cells for Brain Cancer, by Region, Through 2026
Table 10: Global Market for Cancer Stem Cells for Bone Cancer, by Region, Through 2026
Table 11: Global Market for Cancer Stem Cells for Other Cancers, by Region, Through 2026
Table 12: Global Market for Cancer Stem Cells, by Region, Through 2026
Table 13: North American Market for Cancer Stem Cells, by Country, Through 2026
Table 14: North American Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 15: European Market for Cancer Stem Cells, by Country, Through 2026
Table 16: European Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 17: Asia-Pacific Market for Cancer Stem Cells, by Country, Through 2026
Table 18: Asia-Pacific Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 19: RoW Market for Cancer Stem Cells, by Country/Region, Through 2026
Table 20: RoW Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 21: Countries Where Stem Cell Research is Most Prevalent
Table 22: Adnagen: Product Portfolio
Table 23: Advanced Cell Diagnostics: Product Portfolio
Table 24: Apceth Biopharma: Product Portfolio
Table 25: Aviva Biosciences: Product Portfolio
Table 26: BioNTech: Product Portfolio
Table 27: Benitec Biopharma: Product Portfolio
Table 28: Caladrius Biosciences: Product Portfolio
Table 29: Celgene Corp.: Product Portfolio
Table 30: Epic Sciences: Product Portfolio
Table 31: ExCellThera: Product Portfolio
Table 32: Fluxion Biosciences: Product Portfolio
Table 33: Galena Biopharma: Product Portfolio
Table 34: Gamida Cell: Product Portfolio
Table 35: Genexine: Product Portfolio
Table 36: Geron: Product Portfolio
Table 37: ImmunoCellular Therapeutics: Product Portfolio
Table 38: OncoCyte: Product Portfolio
Table 39: OncoMed: Product Portfolio
Table 40: Pluristem Therapeutics: Product Portfolio
Table 41: Silicon Biosystems: Product Portfolio
Table 42: Sphere Fluidics: Product Portfolio
Table 43: ViaCyte Inc.: Product Portfolio
Table 44: Vitatex: Product Portfolio
Table 45: List of North American Patents on Cancer Stem Cells
Table 46: List of European Patents on Cancer Stem Cells
Table 47: List of Asia-Pacific Patents on Cancer Stem Cells
Table 48: List of Row Patents on Cancer Stem Cells
Table 49: Acronyms Used in This Report
Summary Table: Global Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 1: Clinical Trials on Cancer Stem Cells
Table 2: Global Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 3: Global Market for Cancer Stem Cells for Lung Cancer, by Region, Through 2026
Table 4: Global Market for Cancer Stem Cells for Breast Cancer, by Region, Through 2026
Table 5: Global Market for Cancer Stem Cells for Colorectal Cancer, by Region, Through 2026
Table 6: Global Market for Cancer Stem Cells for Leukemia, by Region, Through 2026
Table 7: Global Market for Cancer Stem Cells for Melanoma, by Region, Through 2026
Table 8: Global Market for Cancer Stem Cells for Prostate Cancer, by Region, Through 2026
Table 9: Global Market for Cancer Stem Cells for Brain Cancer, by Region, Through 2026
Table 10: Global Market for Cancer Stem Cells for Bone Cancer, by Region, Through 2026
Table 11: Global Market for Cancer Stem Cells for Other Cancers, by Region, Through 2026
Table 12: Global Market for Cancer Stem Cells, by Region, Through 2026
Table 13: North American Market for Cancer Stem Cells, by Country, Through 2026
Table 14: North American Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 15: European Market for Cancer Stem Cells, by Country, Through 2026
Table 16: European Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 17: Asia-Pacific Market for Cancer Stem Cells, by Country, Through 2026
Table 18: Asia-Pacific Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 19: RoW Market for Cancer Stem Cells, by Country/Region, Through 2026
Table 20: RoW Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 21: Countries Where Stem Cell Research is Most Prevalent
Table 22: Adnagen: Product Portfolio
Table 23: Advanced Cell Diagnostics: Product Portfolio
Table 24: Apceth Biopharma: Product Portfolio
Table 25: Aviva Biosciences: Product Portfolio
Table 26: BioNTech: Product Portfolio
Table 27: Benitec Biopharma: Product Portfolio
Table 28: Caladrius Biosciences: Product Portfolio
Table 29: Celgene Corp.: Product Portfolio
Table 30: Epic Sciences: Product Portfolio
Table 31: ExCellThera: Product Portfolio
Table 32: Fluxion Biosciences: Product Portfolio
Table 33: Galena Biopharma: Product Portfolio
Table 34: Gamida Cell: Product Portfolio
Table 35: Genexine: Product Portfolio
Table 36: Geron: Product Portfolio
Table 37: ImmunoCellular Therapeutics: Product Portfolio
Table 38: OncoCyte: Product Portfolio
Table 39: OncoMed: Product Portfolio
Table 40: Pluristem Therapeutics: Product Portfolio
Table 41: Silicon Biosystems: Product Portfolio
Table 42: Sphere Fluidics: Product Portfolio
Table 43: ViaCyte Inc.: Product Portfolio
Table 44: Vitatex: Product Portfolio
Table 45: List of North American Patents on Cancer Stem Cells
Table 46: List of European Patents on Cancer Stem Cells
Table 47: List of Asia-Pacific Patents on Cancer Stem Cells
Table 48: List of Row Patents on Cancer Stem Cells
Table 49: Acronyms Used in This Report
LIST OF FIGURES
Summary Figure: Global Market Shares of Cancer Stem Cell, by Cancer Type, 2020
Figure 1: Classification of Stem Cells Based on Source
Figure 2: Classification of Stem Cells Based on Source and Marker
Figure 3: Total Cost per Capita of Cancer in Europe (Direct, Indirect and Informal Costs in Each Country), 2018
Figure 4: Incidence of Cancer, 2020
Figure 5: Mortality of Cancer, 2020
Figure 6: Major Issue in Stem Cell Research in Iran, 2017
Figure 7: Number of New Cancer Cases and Mortality Rates Worldwide, by Cancer Type 2020
Figure 8: Global Segmentation of the Market for Cancer Stem Cells, by Cancer Type
Figure 9: Global Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 10: Distribution of New Cases of Lung and Bronchus Cancer, by Age Group, 2020
Figure 11: Global Market for Lungs Cancer in Cancer Stem Cells, by Region, 2019-2026
Figure 12: Distribution of Female Breast Cancer Cases, by Stage at Diagnosis
Figure 13: Breast Cancer Rates in Top Countries, 2020
Figure 14: Global Market for Cancer Stem Cells for Breast Cancer, by Region, 2019-2026
Figure 15: Incidence of Colorectal Cancer Among More and Less Developed Regions, 2018
Figure 16: Global Market for Cancer Stem Cells for Colorectal Cancer, by Region, 2019-2026
Figure 17: Incidence and Mortality Rates of Leukemia in the U.S., 2010-2019
Figure 18: Global Market for Cancer Stem Cells for Leukemia, by Region, 2019-2026
Figure 19: Incidence and Mortality Rates of Melanoma in U.S., 2010-2019
Figure 20: Global Market for Cancer Stem Cells for Melanoma, by Region, 2019-2026
Figure 21: Distribution of New Cases of Melanoma in the U.S., by Age Group, 2021
Figure 22: Global Market for Cancer Stem Cells for Prostate Cancer, by Region, 2019-2026
Figure 23: Global Market for Cancer Stem Cells for Brain Cancer, by Region, 2019-2026
Figure 24: Global Market for Cancer Stem Cells for Bone Cancer, by Region, 2019-2026
Figure 25: Global Market for Cancer Stem Cells for Other Types of Cancer, by Region, 2019-2026
Figure 26: Global Market Shares of Cancer Stem Cells, by Region, 2020
Figure 27: Five Most Common Sites for Estimated New Cancer Cases and Death in U.S., 2021
Figure 28: North American Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 29: New Cases of Cancer in Males in the U.S., 2020
Figure 30: New Cases of Cancer in Females in the U.S., 2020
Figure 31: U.S. Market for Cancer Stem Cells, 2019-2026
Figure 32: Distribution of New Cancer Cases in Canada, 2021
Figure 33: Canadian Market for Cancer Stem Cells, 2019-2026
Figure 34: Cancer Incidence and Mortality in Mexico, 2021
Figure 35: Mexican Market for Cancer Stem Cells, 2019-2026
Figure 36: Predicted Cancer Mortality in Europe, 2021
Figure 37: European Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 38: Cancer Incidence and Mortality in Germany, 2020
Figure 39: German Market for Cancer Stem Cells, 2019-2026
Figure 40: Cancer Incidence and Mortality in France, 2018
Figure 41: French Market for Cancer Stem Cells, 2019-2026
Figure 42: Cancer Incidence in the U.K., 2018
Figure 43: U.K. Market for Cancer Stem Cells, 2019-2026
Figure 44: Cancer Incidence in Italy, 2020
Figure 45: Italian Market for Cancer Stem Cells, 2019-2026
Figure 46: Cancer Incidence in Spain, 2018
Figure 47: Spanish Market for Cancer Stem Cells, 2019-2026
Figure 48: Rest of European Market for Cancer Stem Cells, 2019-2026
Figure 49: Shares of Top Five Countries with Cancer Cases in Asia, 2018
Figure 50: Cancer Incidence in Southeast Asia, 2020
Figure 51: Asia-Pacific Market Shares of Cancer Stem Cell, by Cancer Type, 2020
Figure 52: Cancer Incidence in Japan, by Cancer Type, 2020
Figure 53: Cancer Deaths in Japan, by Cancer Type, 2020
Figure 54: Budget to Control Cancer in Japan, 2003-2015
Figure 55: Japanese Market for Cancer Stem Cells, 2019-2026
Figure 56: Cancer Incidence and Mortality in China, 2020
Figure 57: Chinese Market for Cancer Stem Cells, 2019-2026
Figure 58: Cancer Incidence and Mortality in Australia, 2020
Figure 59: Australian Market for Cancer Stem Cells, 2019-2026
Figure 60: Cancer Incidence and Mortality in India, 2020
Figure 61: Indian Market for Cancer Stem Cells, 2019-2026
Figure 62: Rest of Asia-Pacific Market for Cancer Stem Cells, 2019-2026
Figure 63: Distribution of New Cancer Cases in Latin America and the Caribbean, by Cancer Type, 2020
Figure 64: Distribution of Cancer Deaths in Latin America and the Caribbean, by Cancer Type, 2020
Figure 65: RoW Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 66: Cancer Incidence and Mortality in Brazil, 2020
Figure 67: Brazilian Market for Cancer Stem Cells, 2019-2026
Figure 68: Brazilian Market for Cancer Stem Cells, 2019-2026
Figure 69: Most Common Cancer Cases in Qatar, by Incidence and Mortality, 2020
Figure 70: GCC Countries Market for Cancer Stem Cells, 2019-2026
Figure 71: Other Countries Market for Cancer Stem Cells, 2019-2026
Figure 72: Using MSC Therapy in COVID-19 Patients
Figure 73: How Much Does Stem Cell Therapy Cost?
Figure 74: Global Ranking in the Market for Cancer Stem Cells, by Pharmaceutical Company, 2020
Figure 75: Global Ranking in the Market for Cancer Stem Cells, by Start-up Pharmaceutical Company, 2020
Summary Figure: Global Market Shares of Cancer Stem Cell, by Cancer Type, 2020
Figure 1: Classification of Stem Cells Based on Source
Figure 2: Classification of Stem Cells Based on Source and Marker
Figure 3: Total Cost per Capita of Cancer in Europe (Direct, Indirect and Informal Costs in Each Country), 2018
Figure 4: Incidence of Cancer, 2020
Figure 5: Mortality of Cancer, 2020
Figure 6: Major Issue in Stem Cell Research in Iran, 2017
Figure 7: Number of New Cancer Cases and Mortality Rates Worldwide, by Cancer Type 2020
Figure 8: Global Segmentation of the Market for Cancer Stem Cells, by Cancer Type
Figure 9: Global Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 10: Distribution of New Cases of Lung and Bronchus Cancer, by Age Group, 2020
Figure 11: Global Market for Lungs Cancer in Cancer Stem Cells, by Region, 2019-2026
Figure 12: Distribution of Female Breast Cancer Cases, by Stage at Diagnosis
Figure 13: Breast Cancer Rates in Top Countries, 2020
Figure 14: Global Market for Cancer Stem Cells for Breast Cancer, by Region, 2019-2026
Figure 15: Incidence of Colorectal Cancer Among More and Less Developed Regions, 2018
Figure 16: Global Market for Cancer Stem Cells for Colorectal Cancer, by Region, 2019-2026
Figure 17: Incidence and Mortality Rates of Leukemia in the U.S., 2010-2019
Figure 18: Global Market for Cancer Stem Cells for Leukemia, by Region, 2019-2026
Figure 19: Incidence and Mortality Rates of Melanoma in U.S., 2010-2019
Figure 20: Global Market for Cancer Stem Cells for Melanoma, by Region, 2019-2026
Figure 21: Distribution of New Cases of Melanoma in the U.S., by Age Group, 2021
Figure 22: Global Market for Cancer Stem Cells for Prostate Cancer, by Region, 2019-2026
Figure 23: Global Market for Cancer Stem Cells for Brain Cancer, by Region, 2019-2026
Figure 24: Global Market for Cancer Stem Cells for Bone Cancer, by Region, 2019-2026
Figure 25: Global Market for Cancer Stem Cells for Other Types of Cancer, by Region, 2019-2026
Figure 26: Global Market Shares of Cancer Stem Cells, by Region, 2020
Figure 27: Five Most Common Sites for Estimated New Cancer Cases and Death in U.S., 2021
Figure 28: North American Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 29: New Cases of Cancer in Males in the U.S., 2020
Figure 30: New Cases of Cancer in Females in the U.S., 2020
Figure 31: U.S. Market for Cancer Stem Cells, 2019-2026
Figure 32: Distribution of New Cancer Cases in Canada, 2021
Figure 33: Canadian Market for Cancer Stem Cells, 2019-2026
Figure 34: Cancer Incidence and Mortality in Mexico, 2021
Figure 35: Mexican Market for Cancer Stem Cells, 2019-2026
Figure 36: Predicted Cancer Mortality in Europe, 2021
Figure 37: European Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 38: Cancer Incidence and Mortality in Germany, 2020
Figure 39: German Market for Cancer Stem Cells, 2019-2026
Figure 40: Cancer Incidence and Mortality in France, 2018
Figure 41: French Market for Cancer Stem Cells, 2019-2026
Figure 42: Cancer Incidence in the U.K., 2018
Figure 43: U.K. Market for Cancer Stem Cells, 2019-2026
Figure 44: Cancer Incidence in Italy, 2020
Figure 45: Italian Market for Cancer Stem Cells, 2019-2026
Figure 46: Cancer Incidence in Spain, 2018
Figure 47: Spanish Market for Cancer Stem Cells, 2019-2026
Figure 48: Rest of European Market for Cancer Stem Cells, 2019-2026
Figure 49: Shares of Top Five Countries with Cancer Cases in Asia, 2018
Figure 50: Cancer Incidence in Southeast Asia, 2020
Figure 51: Asia-Pacific Market Shares of Cancer Stem Cell, by Cancer Type, 2020
Figure 52: Cancer Incidence in Japan, by Cancer Type, 2020
Figure 53: Cancer Deaths in Japan, by Cancer Type, 2020
Figure 54: Budget to Control Cancer in Japan, 2003-2015
Figure 55: Japanese Market for Cancer Stem Cells, 2019-2026
Figure 56: Cancer Incidence and Mortality in China, 2020
Figure 57: Chinese Market for Cancer Stem Cells, 2019-2026
Figure 58: Cancer Incidence and Mortality in Australia, 2020
Figure 59: Australian Market for Cancer Stem Cells, 2019-2026
Figure 60: Cancer Incidence and Mortality in India, 2020
Figure 61: Indian Market for Cancer Stem Cells, 2019-2026
Figure 62: Rest of Asia-Pacific Market for Cancer Stem Cells, 2019-2026
Figure 63: Distribution of New Cancer Cases in Latin America and the Caribbean, by Cancer Type, 2020
Figure 64: Distribution of Cancer Deaths in Latin America and the Caribbean, by Cancer Type, 2020
Figure 65: RoW Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 66: Cancer Incidence and Mortality in Brazil, 2020
Figure 67: Brazilian Market for Cancer Stem Cells, 2019-2026
Figure 68: Brazilian Market for Cancer Stem Cells, 2019-2026
Figure 69: Most Common Cancer Cases in Qatar, by Incidence and Mortality, 2020
Figure 70: GCC Countries Market for Cancer Stem Cells, 2019-2026
Figure 71: Other Countries Market for Cancer Stem Cells, 2019-2026
Figure 72: Using MSC Therapy in COVID-19 Patients
Figure 73: How Much Does Stem Cell Therapy Cost?
Figure 74: Global Ranking in the Market for Cancer Stem Cells, by Pharmaceutical Company, 2020
Figure 75: Global Ranking in the Market for Cancer Stem Cells, by Start-up Pharmaceutical Company, 2020
